Pace Gary W's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Mar 1, 2022
- Accession no.
- 0001209191-22-014267
- Filed
- Mar 1, 2022
- Trade date
- Feb 28-Mar 1, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.01M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pace Gary WCIK 0001184778 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | MOption exerciseAcquired | +9,807 | $11.02 | +$108,073.14 | 139,337 | Direct | |
| Feb 28, 2022 | Common Stock | MOption exerciseAcquired | +18,834 | $11.02 | +$207,550.68 | 158,171 | Direct | |
| Feb 28, 2022 | Common Stock | SSaleDisposed | −28,641 | $66.83F1 | −$1,914,078.03 | 129,530 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +193 | $11.02 | +$2,126.86 | 129,723 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +1,166 | $11.02 | +$12,849.32 | 130,889 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −1,359 | $67.75 | −$92,072.25 | 129,530 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | MOption exerciseDisposed | −9,807 | $0.00 | $0 | 193 | Direct | |
| Feb 28, 2022 | Common Stock | MOption exerciseDisposed | −18,834 | $0.00 | $0 | 1,166 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −193 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −1,166 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
he price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.750 to $67.155, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.